Gelmetix

About:

Gelmetix is a medical device company developing a polymer treatment for chronic lower-back pain.

Website: https://www.gelmetix.com

Top Investors: University of Manchester, Jonathan Milner, Fund Twenty8, Wealth Club, Seneca Partners

Description:

Gelmetix develops multiple grades of polymer gel to provide affordable non-invasive alternatives to surgery for conditions like Chronic Lower Back pain and Osteoarthritis. Their lead product is a hydrogel for nucleus pulposus augmentation to relieve pain in patients suffering from Chronic Low Back Pain. Gelmetix is a diversified therapeutic biomaterials company incorporated in the UK. It has offices in London, Paris, and Manchester.

Total Funding Amount:

10.3M GBP

Headquarters Location:

Macclesfield, Cheshire East, United Kingdom

Founded Date:

2012-01-01

Contact Email:

contact(AT)gelmetix.com

Founders:

Brian R Saunders, Philippe Jenny, Tony Freemont

Number of Employees:

11-50

Last Funding Date:

2021-05-14

IPO Status:

Private

Industries:

© 2025 bioDAO.ai